We characterize a consanguineous Egyptian family with an autosomal recessively inherited familial cortical myoclonic tremor and epilepsy. We used multipoint linkage analysis to map the causative mutation to a 12.7 megabase interval within 1q31.3-q32.2 with a log of odds score of 3.6. For further investigation of the linked region in an efficient and unbiased manner, we performed exome sequencing. Within the suspected region we identified a homozygous single base pair deletion (c.503_503delG) leading to a frameshift in the coding region of the sixth exon of CNTN2 alias TAG-1 (p.Trp168fs), which segregated in the respective family. Many studies point towards an important role of the CNTN2 product contactin 2 in neuronal excitability. Contactin 2, a glycosylphosphatidylinositol-anchored neuronal membrane protein, and another transmembrane protein called contactin associated protein-like 2 (CNTNAP2 alias CASPR2) are together necessary to maintain voltage-gated potassium channels at the juxtaparanodal region. CNTN2 knockout mice were previously reported to suffer from spontaneous seizures and mutations in the CNTNAP2 gene have been described to cause epilepsy in humans. To further delineate the role of CNTN2 in patients with epilepsy, we sequenced the coding exons in 189 Caucasian patients with epilepsy. No recessive mutation was detected and heterozygote carriers of rare CNTN2 variants do not seem to be predisposed to epilepsy. Given the severity of the mutation and the proposed function of the gene, we consider this mutation as the most likely cause for cortical myoclonic tremor and epilepsy in this family.
Introduction
Familial cortical myoclonic tremor with epilepsy, familial adult myoclonic epilepsy, benign adult familial myoclonic epilepsy, and autosomal dominant cortical myoclonus and epilepsy are rare, but well described overlapping clinical syndromes (van Rootselaar et al., 2005; Striano et al., 2010; Coppola et al., 2011) . Familial cortical myoclonic tremor with epilepsy is characterized by an autosomal dominant inheritance, cortical myoclonic tremor, and occurrence of epileptic seizures. Nevertheless, marked clinical heterogeneity is observed. Age at onset may vary considerably, with most cases starting within the second decade of life. Usually action-and posture-induced myoclonic tremor is the presenting symptom, characterized by tremulous finger movements and myoclonic jerks of the limbs. In a minority of patients, epileptic seizures are the presenting symptom; both complex partial as well as generalized tonic clonic seizures are described. Some patients exhibit mild cognitive impairment, and recently a relatively high psychiatric comorbidity was described (Coppola et al., 2011) . Although a slight worsening of symptoms in advanced age is reported, the majority of patients seem to show a benign non-progressive course on anti-epileptic therapy. Both, clinical and electrophysiological features suggest cortical hyperexcitability, which might be consistent with a channelopathy; however, so far the underlying pathophysiology remains speculative (van Rootselaar et al., 2005; Coppola et al., 2011) . To date, different families in Europe and Japan and three autosomal dominant inherited loci have been described, indicating genetic heterogeneity [8q24 (MIM 601068), 2p11.1-q12.2 (MIM 607876), 5p15.31-p15.1 (MIM 613608)] (Mikami et al., 1999; Guerrini et al., 2001; Depienne et al., 2010) . A causative gene could not be detected (Mori et al., 2011; Crompton et al., 2012) . We investigated a consanguineous Egyptian family exhibiting a clinical phenotype showing marked similarities with familial cortical myoclonic tremor with epilepsy, however segregating as an autosomal recessive trait.
Subjects and methods

Clinical data
We investigated a consanguineous Egyptian family with an autosomal recessive mode of inheritance ( Fig. 1) , in which five siblings of healthy parents had a similar clinical phenotype of cortical myoclonic tremor and epilepsy (Table 1) . The parents were known to be second cousins, as the father's grandmother and the mother's grandfather were siblings. All affected siblings are under medical treatment at the University of Ain Shams, Cairo, Egypt. All patients and parents gave written informed consent; the study was approved by the local ethics committee.
For the screening of possible mutations of CNTN2 in a larger sample of patients with epilepsy we selected 170 Austrian patients with temporal lobe epilepsy and 19 Italian patients, exhibiting in part focal epilepsies with auditory features and in part myoclonic seizures. All patients are under treatment at the Medical University of Vienna, Austria and at the Medical University of Florence, Italy, respectively. Written informed consent was obtained from all study participants; the study was approved by the local ethics committee.
The control individuals for testing detected putative pathogenic variants consisted of 366 healthy Austrian blood donors (145 females, 221 males, mean age 40 years) and 148 healthy control individuals from different regions of North Africa (36 individuals from Egypt, 95 individuals from Algeria, 14 individuals from Morocco and three individuals from Tunisia; 80 females, 68 males, mean age 50 years). All study participants gave written informed consent; the study was approved by the local ethics committee.
Genetic data
We performed genome-wide linkage analysis in all five affected family members (Patients V-1, V-3, V-4, V-6 and V-7) using Affymetrix Gene Chip Human Mapping 10K Xba142 2.0 arrays. Data for linkage analysis were prepared with a modified version of Alohomora (Ruschendorf and Nurnberg, 2005) . Multipoint linkage analysis was achieved using Allegro (version1.1d) (Gudbjartsson et al., 2000) . We assumed an autosomal recessive model. The frequency of the deleterious allele was set to 0.001, and the penetrance to 99% (q = 0.001; f 1 = 0.0; f 2 = 0.0; f 3 = 0.99).
Whole exome sequencing was performed for two affected family members (Patients V-3 and V-6). Libraries for the two exomes were prepared following standard protocols using the SureSelect whole Exome Assay. Sequencing of post-enrichment libraries was carried out on an Illumina Genome Analyzer IIx as 54 bp paired-end runs. For each sample, two lanes of a flow cell were sequenced. Image analysis and base calling was carried out using the Genome Analyzer Pipeline version 1.5 with default parameters. Alignment of the reads to the hg19 reference sequence was performed with the BWA software (v.0.5.8) using mainly default parameters. Reads were trimmed of low quality bases at the end (-q) using a cut-off quality of 15. A small number (3-4%) of duplicated reads, which were indicated by identical outer co-ordinates of mapped mate pairs, were removed. The percentage of reads overlapping targeted regions and coverage statistics of targeted regions were calculated using Perl scripts. Mapped reads that directly overlapped the targeted regions were used for variant identification. About 6.5-7.0 Gb of map able sequence data were generated per individual with 34-39% of reads mapping to the target regions. On average, 498% of the targeted bases were covered at least once, and 475% of bases were covered 20-fold or more. Initially, 29 185 and 29 755 variants for the two samples including single nucleotide polymorphisms and indels using SAMtools (v. 0.1.7) were called, respectively. For the variant filter part of SAMtools default parameters with the exception of setting a maximum read depth of 9999 (parameter-D) was used. Additional filters were applied to exclude low confidence variants: median base quality of the variant base of at least 15, a minimum of 15% of reads showing the variant base and that the variant base is indicated by at least 5% of reads coming from different strands. For indels it was required that at least 10% of reads covering this position to indicate the indel. Variant annotation was performed using custom Perl scripts. For prioritization, known single nucleotide polymorphisms from dbSNP build 130, from eight sequenced exomes of Hap Map samples (Ng et al., 2010) and from 72 control exomes of the in-house database were excluded (EXOME control database, Helmholtz Centre Munich). Finally, the analysis was confined to the linkage region chr1: 197 386 847-210 109 286 (UCSC genome build hg19). All variants that were shared between the two samples were selected.
TaqMan Õ allelic discrimination assays were developed for all three variants derived from the Exome sequencing and genotyped in (i) seven members of the Egyptian family (Patients IV-1, IV-2, V-1, V-3, V-4, V-6 and V-7); (ii) 
Clinical data
Pedigree and clinical data of the described family are shown in Fig. 1 and Table 
Genetic data Linkage analysis and whole exome sequencing
Assuming an autosomal recessive model, significant linkage with a log of odds (LOD) score of 3.6 was obtained on chromosome 1q31.3-q32.2 between rs927510 and rs724054 ( Supplementary  Fig. 1 ). This 12.7 Mb region contains 153 annotated known and predicted genes (UCSC genomes build hg19, chr1: 197 386 847-210 109 286). To identify the disease causing variant, we selected two siblings (Patients V-3 and V-6) for whole exome sequencing. We filtered called variants as described above. We assumed that any homozygous variant within the linked region would be a disease candidate. This approach left three homozygous non-synonymous variants shared by both affected individuals within the candidate region: (i) c.844G4C (p.Glu282Gln) in the DDX59 gene. The encoded protein DDX59 is a probable ATP-dependent RNA helicase; publicly available data show only very low expression in the brain (UCSC genome browser); (ii) c.506C4A (p.Ser169Tyr) in the TNNI1 gene. The encoded protein, TNNI1, is expressed in cardiac and skeletal muscle during early development, but is restricted to slow-twitch skeletal muscle fibres in adults. TNNI1 prevents muscle contraction by inhibiting calcium-mediated conformational changes in actin-myosin complexes (Kee and Hardeman, 2008) ; and (iii) c.503_503delG (p.Trp168fs), a single nucleotide deletion, which results in a frameshift downstream of this position in the CNTN2 gene (also known as TAG-1) (Fig. 1) . The gene product contactin 2 is a glycosylphosphatidylinositol-anchored neuronal membrane protein that contributes in conjunction with another transmembrane protein called contactin associated protein-like 2 to the organization of axonal domains at nodes of Ranvier, by maintaining voltage-gated potassium channels at the juxtaparanodal region . All three variants of the three respective genes (DDX59, TNNI1 and CNTN2) were confirmed to be in a homozygous state in all affected subjects of the family and in a heterozygous state in the parents. None of these variants were present in the screened Austrian and Italian patients with epilepsy, nor in the Austrian and Egyptian control cohort. Considering expression as well as experimental data, which suggest an important role of CNTN2 in cortical neuronal hyperexcitability, CNTN2 seemed to be the most plausible candidate gene for a disorder like familial cortical myoclonic tremor with epilepsy.
Rare variants of CNTN2 among epilepsy cases and their frequency in control subjects
To assess the prevalence of other CNTN2 mutations among epilepsy cases, we screened all 22 coding exons of CNTN2 by capillary sequencing in 189 patients with various epilepsy syndromes. Seven novel variants, found in the patient cohort, and not present in dbSNP build 132, were genotyped in 402 control individuals. Furthermore we surveyed the exonic region of 1200 control individuals from an in-house database containing whole-exome sequencing data from 1200 individuals (EXOME control database, Helmholtz Centre Munich). Overall, in addition to c.503_503delG, 30 rare non-synonymous variants were identified. Rare was defined as present with a heterozygote allele frequency of 50.02 and/or no deposition in dbSNP build 132 (Supplementary  Table 1 ). No homozygous variant was detected. We identified three different heterozygous non-synonymous variants only present in the patient group, five present in the patient and control groups and 22 only present in the EXOME control group. Eighty-five individuals (7, 1%) in the EXOME control group and 10 individuals (5, 3%) in the patient group carried a rare heterozygous non-synonymous variant. Taken together, neither the amount of rare non-synonymous variants nor the number of individuals carrying such a variant was higher in the patient group than in the EXOME control group.
Discussion
We investigated a consanguineous Egyptian family with an autosomal recessively inherited familial cortical myoclonic tremor with epilepsy. By performing linkage analysis and subsequent exome sequencing, we detected a single nucleotide deletion in exon 6 of CNTN2 (c.503_503delG) resulting in a frameshift mutation (p.Trp168fs), segregating in a recessive manner in the family. The CNTN2 product contactin 2 is a well described neuronal cell adhesion molecule that belongs to the contactin subgroup of the immunoglobulin superfamily (Poliak and Peles, 2003; Traka et al., 2003) . The CNTN2 gene is expressed by neurons and myelinating glial cells and is essential for the organization of juxtaparanodal regions in myelinated fibres (Poliak and Peles, 2003; Savvaki et al., 2008) . Several studies show that contactin 2 and another transmembrane molecule called contactin associated protein-like 2 form a scaffold that enables the accumulation of voltage-gated potassium channels at the juxtaparanodes Horresh et al., 2008) . Voltage-gated potassium channels have been known for a long time to play a critical role in stabilizing membrane potential and modulating action potential frequency during repetitive firing (Smart et al., 1998) . In CNTN2-deficient mice contactin associated protein-like 2 did not accumulate at juxtaparanodes, and the normal enrichment of voltage-gated potassium channels was severely disrupted Traka et al., 2003) . Many studies point towards an important role of contactin 2 and associated proteins in cortical hyperexcitability and seizure susceptibility. CNTN2-deficient mice show spontaneous epileptic seizures, and increased seizure susceptibility to convulsant stimuli (Fukamauchi et al., 2001) . Mice lacking voltage gated potassium channels (K v 1.1 and K v 1.2) exhibit increased seizure susceptibility and hyperexcitability in axons (Smart et al., 1998; Brew et al., 2007) . There is also evidence for a critical role of this tripartite complex in cortical hyperexcitability in humans. Mutations in the gene encoding contactin associated protein-like 2 (CNTNAP2) were reported to cause recessive symptomatic focal epilepsy with mental retardation in Old Order Amish People (Strauss et al., 2006) . Mutations in the KCNA1 gene, encoding the voltage-gated potassium channel K v 1.1, are known to cause episodic ataxia type 1, and epileptic seizures show a significant over-representation in these families (Zuberi et al., 1999) .
Besides the described deletion in exon 6 of CNTN2, we detected two further homozygous missense variants within the putative linkage region 1q31.3-q32.2 (DDX59 p.Glu282Gln and TNNI1 p.Ser169Tyr). The respective encoded proteins are hardly expressed in the brain and their putative function does not suggest a relevant role in cortical neuronal hyperexcitability, which is the most likely pathophysiological background of cortical tremor and epilepsy. In contrast, given the expression and experimental data, as well as the impact of a loss of function mutation, we consider CNTN2 as the most likely candidate gene. However, we cannot completely exclude an additional effect of these genes to the described phenotype, acting in combination with the mutated CNTN2.
The five affected patients showed a similar clinical picture with an onset of symptoms in adolescence, presenting with epileptic seizures, followed by appearance of a mild irregular tremor of the head and upper limbs. Clinical and EEG data suggested a focal, likely temporal origin of epileptic seizures. In one patient, brain MRI revealed bilateral mesial hippocampal sclerosis, previously not observed in this syndrome. Another patient in this family had severe seizures, although a progressive course of the syndrome was not apparent. Our patients exhibited cortical myoclonic tremor typical for familial cortical myoclonic tremor and epilepsy, described as irregular twitching of the fingers insensitive to beta-blocker therapy. Surface electromyographic investigations showed synchronous bursting of agonist and antagonist muscles with a frequency of 10-14 Hz and burst duration 550 ms, typical for a cortical origin of myoclonus. Somatosensory evoked potentials were normal, as also reported in other patients (Crompton et al., 2012) . In line with previous observations in familial cortical myoclonic tremor with epilepsy, some family members exhibited borderline cognitive level and psychiatric symptoms (Coppola et al., 2011) .
As CNTN2 seemed to be a likely candidate gene for influencing neuronal excitability, to further delineate its role, we sequenced all coding exons in 189 patients with epilepsy. We did not detect homozygous mutations, and neither the amount of rare variants nor the number of individuals carrying rare heterozygote variants was higher in the patient group than in the control group. Thus, heterozygote carriers of rare CNTN2 variants do not seem to be predisposed to the examined epilepsies.
The present study, therefore, presents an interesting, already known gene called CNTN2 as the most likely underlying cause in a family with autosomal recessive cortical myoclonic tremor and epilepsy, showing marked similarities with the well-known phenotype of familial cortical myoclonic tremor with epilepsy. The crucial role of CNTN2 in neuronal excitability makes this gene a plausible candidate for familial cortical myoclonic tremor with epilepsy. Its identification contributes to elucidating the pathogenesis of familial cortical myoclonic tremor with epilepsy and, considering that cortical myoclonic tremor is observed across a wide number of epileptic disorders (Grosse et al., 2003) , may provide clues in understanding the molecular basis of more common types of epilepsy.
